Farmax India (Delisted) share news and announcements

BSE: 590094

Last traded ₹0.05 on 2 Jul 2018

Delisted on 6 Apr 2017.

Last results date

The last board meeting held for results; the company has not yet given notice of the next.Farmax India quarterly results

Nov14Wed

The board met on 14 Nov 2018 to consider financial results

Notice filed 8 Nov 2018

To consider and approve the financial results for the period ended September 30, 2018 (opens in a new tab)

Farmax India annual reports, presentations and earnings calls

The company's own documents, latest first.Farmax India financials, year by year

Annual reports7

Annual report, year to Mar 2016 (opens in a new tab)30 Sep 2016
Annual report, year to Mar 2015 (opens in a new tab)5 Sep 2015
Annual report, year to Mar 2012 (opens in a new tab)21 Jul 2015
Annual report, year to Mar 2013 (opens in a new tab)21 Jul 2015
Annual report, year to Mar 2014 (opens in a new tab)9 Sep 2014

2 earlier reports

Annual report, year to Mar 2011 (opens in a new tab)31 Oct 2011
Annual report, year to Mar 2010 (opens in a new tab)Filing day not known

Farmax India share news and announcements

383 announcements, routine notices left out, newest first. Page 1 of 8.

Jun 2020
- 18 Jun · Delisting
  Members of the Exchange are hereby notified that in terms of Regulations of the Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009, Section 21A of the Securities Contract (Regulations) Act, 1956, Securities Contract (Regulations) Rules, 1957 and Bye-Laws of the Exchange, it has been decided to delist (withdraw the admission to dealings in) equity shares of Farmax India Limited (FARMAXIND) w.e.f. July 10, 2020 as per SEBI (Delisting of Equity Shares) Regulations, 2009. (opens in a new tab)
Dec 2019
- 2 Dec · Public Announcement - Delisting
  Members of the Exchange are hereby informed that the Exchange on November 26, 2019 has issued public notice in the newspaper for proposed compulsory delisting of equity shares of the company, in term of Regulation 22 (3) of SEBI (Delisting of Equity shares) Regulation, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/common/Corporate Announcements). (opens in a new tab)
Nov 2018
- 8 Nov · Board meeting
  To consider and approve the financial results for the period ended September 30, 2018 (opens in a new tab)
Sep 2018
- 29 Sep · Meeting
  Proceedings of Annual General Meeting held on September 29, 2018 (opens in a new tab)
Aug 2018
- 9 Aug · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2018 (opens in a new tab)
May 2018
- 30 May · Legal
  Exchange has sought clarification from Farmax India Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed under Schedule III of the Companies Act, 2013. -2. Financial results not submitted as per Indian Accounting Standard. -3. Standalone Reconciliation of profit and loss not submitted -4. Standalone Reconciliation of Equity not submitted. The response of the Company is awaited.
- 29 May · Results
  Financial results for the period ended March 31, 2018. (opens in a new tab)
- 29 May · Board meeting
  Board meeting held on May 29, 2018. Declaration of audited financials and audited report for the financial quarter and year ended 31.03.2018. (opens in a new tab)
- 24 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2018 (opens in a new tab)
- 2 May · Meeting
  Copy Srutinizers report of Extraordinary General Meeting held on April 30, 2018. Further, the company has informed the Exchange regarding voting results. (opens in a new tab)
Apr 2018
Feb 2018
- 16 Feb · Legal
  Exchange has sought clarification from Farmax India Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results not submitted within 30 minutes from end of board meeting. -2. Financial results not submitted as per Schedule III to the Companies Act, 2013 -3. Financial results not submitted as per Ind-AS format. -4. Reconciliation of profit and loss not submitted. The response of the Company is awaited.
- 16 Feb · Board meeting
  Board meeting held on February 14, 2018 in relation approval of OTS proposal from State Bank of India. (opens in a new tab)
- 14 Feb · Board meeting
  Outcome of Board Meeting held on February 14, 2018. (opens in a new tab)
- 14 Feb · Results
  Financial results for the period ended 31-Dec-2017. (opens in a new tab)
- 9 Feb · Board meeting
  To transact the following business: (1) To consider , approve and take on record un-audited quarterly financial results for the quarter ended December 31, 2017.(2) To consider and approve the State Bank of India OTS (One Time Settlement) proposal.(3) Any other business with the permission of the Board. (opens in a new tab)
- 8 Feb · Legal
  Exchange has sought clarification from Farmax India Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results not submitted within 30 minutes from end of board meeting. -2. Segment details not submitted. -3. Board meeting notice not submitted. -4. Reconciliation of profit and loss not submitted. The response of the Company is awaited.
- 8 Feb · Legal
  Exchange has sought clarification from Farmax India Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results not submitted within 30 minutes from end of board meeting. -2. Financial results not submitted as per Schedule III to the Companies Act, 2013 -3. Financial results not submitted as per Ind-AS format -4. Board meeting notice not submitted -5. Reconciliation of profit and loss not submitted -6. Balance sheet statement not submitted The response of the Company is awaited.
- 6 Feb · Results
  Financial results for the period ended September 30, 2017. (opens in a new tab)
- 6 Feb · Results
  Financial results for the period ended June 30, 2017. (opens in a new tab)
May 2017
- 30 May · Results
  Financial results for the period ended 31-Mar-2017. (opens in a new tab)
- 17 May · Board meeting
  To consider and approve the following: 1 . Audited Q4 results for the Quarter ended March 31, 2017 . 2. Audit Report for the Quarter ended March 31, 2017 3. Any other business with the permission of the Chair. (opens in a new tab)
Apr 2017
- 5 Apr · Disclosure
  Vide letter dated April 03, 2017 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
Mar 2017
- 17 Mar · Legal
  Exchange had sought clarification from Farmax India Limited with respect to announcement dated 16-Mar-2017, regarding "Farmax India Limited has informed the Exchange that at the meeting of the company held on March 16, 2017, the following were considered and approved: 1. Resignation of Vara Prasad, C.F.O.". On basis of above the Company is required to clarify following: 1. Date of appointment/cessation (as applicable) & term of appointment;The response of the Company is attached. (opens in a new tab)
- 16 Mar · Legal
  Exchange has sought clarification from Farmax India Limited with respect to announcement dated 16-Mar-2017, regarding "Farmax India Limited has informed the Exchange that at the meeting of the company held on March 16, 2017, the following were considered and approved: 1. Resignation of Vara Prasad, C.F.O.". On basis of above the Company is required to clarify following: 1. Date of appointment/cessation (as applicable) & term of appointment;The response of the Company is awaited.
- 16 Mar · Board meeting
  At the meeting of the company held on March 16, 2017, the following were considered and approved: 1. Resignation of Vara Prasad, C.F.O. (opens in a new tab)
- 14 Mar · Board meeting
  To consider and approve the following : (1) Resignation of Vara Prasad, C.F.O.(2) Any other matter with the permission of chair. (opens in a new tab)
Feb 2017
- 13 Feb · Results
  1. Standalone Financial Results for the period ended December 31, 2016 2. Consolidated Financial Results for the period ended December .... (opens in a new tab)
- 13 Feb · Results
  Financial results for the period ended December 31, 2016. (opens in a new tab)
Jan 2017
- 31 Jan · Board meeting
  To consider and approve the following: 1. Unaudited Q3 results for the quarter December 31, 2016. 2. Limited review report for the quarter ended December 31, 2016. 3. Any other business with the permission of the Chair. (opens in a new tab)
- 21 Jan · Shareholding for the Period Ended December 31, 2016
  Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click ....
- 11 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
  Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of .... (opens in a new tab)
Dec 2016
- 26 Dec · Updates
  Company has submitted closure letter of Farmax International FZE to RBI on December 08, 2016. (opens in a new tab)
- 24 Dec · Intimation of Subsidiary Closure
  Company has submitted closure letter of Farmax International FZE to RBI on December 08, 2016. (opens in a new tab)
Nov 2016
Oct 2016
- 25 Oct · Board meeting
  To consider and approve the following : (1) Unaudited Q2 results for the quarter ended September 30, 2016.(2) Limited Review report for the quarter ended September 30, 2016.(3) Any other business with the permission of the Chair. (opens in a new tab)
- 14 Oct · Shareholding for the Period Ended September 30, 2016
  Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click ....
- 14 Oct · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
  Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) .... (opens in a new tab)
- 1 Oct · Results
  Details of Voting results at the 21st Annual General Meeting (AGM) of the Company held on September 30, 2016, under Regulation 44(3) of SEBI .... (opens in a new tab)
- 1 Oct · Regulation 44(3) of SEBI (LODR), Reg., 2015
  Details of voting results of the Annual General Meeting of the Company held on the September 30, 2016 along with Report of Scrutinizer. (opens in a new tab)
- 1 Oct · Meeting
  The 21st Annual General Meeting (AGM) of the Company was held on September 30, 2016. (opens in a new tab)
Sep 2016

How the price met the news

The first session after each announcement, beside the market.

That dayAgainst the Nifty 500Market median on that newsFive sessionsFive sessions against the Nifty 500Volume, times usual

30 Oct 2014Board or managers changed0.00%−0.9 pts vs Nifty 500market median 0.0% · five sessions −5.0% (−8.2 pts vs Nifty 500) · volume 0.7× usual · The announcement (opens in a new tab)
16 Sep 2011Board or managers changeddown 2.04%−2.2 pts vs Nifty 500market median 0.0% · five sessions +10.2% (+12.7 pts vs Nifty 500) · volume 0.5× usual

Sharp moves

The latest 30. 26 of the 30 shown had no filing that day or the next.

MoveAgainst the Nifty 500Times its usual moveVolume, times usualFilings

27 Feb 2017No filing that day or the nextdown 33.33%−33.0 pts vs Nifty 5001.4× its usual move · volume 0.7× usual
23 Feb 2017No filing that day or the nextup 50.00%+49.9 pts vs Nifty 5002.2× its usual move · volume 1.1× usual
22 Feb 2017No filing that day or the nextdown 33.33%−33.3 pts vs Nifty 5001.5× its usual move · volume 41.1× usual
14 Feb 20172 filingsup 50.00%+50.3 pts vs Nifty 5002.1× its usual move · volume 0.6× usual
10 Feb 2017No filing that day or the nextdown 33.33%−33.4 pts vs Nifty 5001.4× its usual move · volume 0.5× usual
2 Feb 2017No filing that day or the nextup 50.00%+49.6 pts vs Nifty 5002.1× its usual move · volume 4.2× usual
27 Jan 2017No filing that day or the nextdown 33.33%−33.8 pts vs Nifty 5001.4× its usual move · volume 0.6× usual
25 Jan 2017No filing that day or the nextup 50.00%+48.6 pts vs Nifty 5002.2× its usual move · volume 0.6× usual
13 Jan 2017No filing that day or the nextdown 33.33%−33.3 pts vs Nifty 5001.5× its usual move · volume 0.0× usual
12 Jan 20171 filingup 50.00%+48.6 pts vs Nifty 5002.3× its usual move · volume 0.0× usual

20 earlier moves

28 Dec 2016No filing that day or the nextdown 33.33%−33.6 pts vs Nifty 5001.3× its usual move · volume 0.0× usual
27 Dec 2016No filing that day or the nextup 50.00%+48.4 pts vs Nifty 5002.0× its usual move · volume 0.8× usual
26 Dec 20162 filingsdown 33.33%−32.0 pts vs Nifty 5001.3× its usual move · volume 1.1× usual
22 Dec 2016No filing that day or the nextup 50.00%+51.2 pts vs Nifty 5002.0× its usual move · volume 0.4× usual
21 Dec 2016No filing that day or the nextdown 33.33%−33.2 pts vs Nifty 5001.3× its usual move · volume 0.0× usual
20 Dec 2016No filing that day or the nextup 50.00%+51.0 pts vs Nifty 5002.1× its usual move · volume 0.2× usual
8 Dec 2016No filing that day or the nextdown 33.33%−35.0 pts vs Nifty 5001.3× its usual move · volume 4.0× usual
7 Dec 2016No filing that day or the nextup 50.00%+50.4 pts vs Nifty 5002.1× its usual move · volume 0.0× usual
6 Dec 2016No filing that day or the nextdown 33.33%−33.6 pts vs Nifty 5001.4× its usual move · volume 0.2× usual
22 Nov 2016No filing that day or the nextup 50.00%+48.9 pts vs Nifty 5002.0× its usual move · volume 2.3× usual
21 Nov 2016No filing that day or the nextdown 33.33%−31.2 pts vs Nifty 5001.3× its usual move · volume 0.3× usual
17 Nov 2016No filing that day or the nextup 50.00%+50.4 pts vs Nifty 5002.0× its usual move · volume 1.1× usual
11 Nov 20162 filingsdown 33.33%−30.4 pts vs Nifty 5001.3× its usual move · volume 0.1× usual
8 Nov 2016No filing that day or the nextup 50.00%+49.5 pts vs Nifty 5002.0× its usual move · volume 0.9× usual
3 Nov 2016No filing that day or the nextdown 33.33%−32.7 pts vs Nifty 5001.3× its usual move · volume 0.1× usual
19 Oct 2016No filing that day or the nextup 50.00%+50.1 pts vs Nifty 5001.8× its usual move · volume 1.3× usual
26 Sep 2016No filing that day or the nextdown 33.33%−32.3 pts vs Nifty 5001.2× its usual move · volume 4.7× usual
23 Sep 2016No filing that day or the nextup 50.00%+50.2 pts vs Nifty 5001.8× its usual move · volume 3.4× usual
19 Sep 2016No filing that day or the nextdown 33.33%−33.7 pts vs Nifty 5001.2× its usual move · volume 0.1× usual
12 Sep 2016No filing that day or the nextup 50.00%+52.0 pts vs Nifty 5001.7× its usual move · volume 0.1× usual

Last results date

Farmax India annual reports, presentations and earnings calls

Annual reports7

Farmax India share news and announcements

Jun 2020

Dec 2019

Nov 2018

Sep 2018

Aug 2018

May 2018

Apr 2018

Feb 2018

May 2017

Apr 2017

Mar 2017

Feb 2017

Jan 2017

Dec 2016

Nov 2016

Oct 2016

Sep 2016

How the price met the news

Sharp moves